Adiposity and Immunometabolism in Sepsis

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

July 31, 2025

Conditions
ObesitySepsis
Interventions
OTHER

Diagnosis of sepsis

Patients will be recruited on the basis of a diagnosis of sepsis, as this is the exposure of interest

Trial Locations (1)

G51 4TF

Department of Critical Care Medicine, Queen Elizabeth University Hospital, Glasgow

All Listed Sponsors
collaborator

University of Glasgow

OTHER

lead

NHS Greater Glasgow and Clyde

OTHER

NCT06307509 - Adiposity and Immunometabolism in Sepsis | Biotech Hunter | Biotech Hunter